Message

Nanobiotechnology has been recognized as a key research agenda for cancer care, blood disorders, diabetes, heart diseases, stroke, dengue, malaria, chikungunya, tuberculosis, environmental toxin on human health and water. It promotes innovative scientific research, reduces diseases burden and supports economic growth and the efficient use of resources.

In this context, global and regional research cooperation is more important than ever. It is the only way to curb human suffering and move toward a better world with healthier environment.

Nanobiotechnology provides an in-depth analysis of each product, process and protocol to help bridge the gaps in medical knowledge, an essential tool to ensure more inclusive participation in biomedical research. Effective research facilitation implementation and knowledge flow into development of diagnostic, vaccine development, treatment protocol, monitoring and modelling of non-communicable diseases require inclusive and holistic approaches.

Rapid developments in nanobiotechnology, immunobiology, cell biology, molecular biology, drug therapy hold great promise in addressing these challenges.

New technologies, such as distributed ledger technology and artificial intelligence, can significantly reduce process inefficiency and enable faster assessment of experiments with less room for human error.

Greater involvement from national governments, regional institutions and international research bodies can also help address the persistent, unmet demand for medical research by strengthening support for nanobiotechnology research agenda.